211 related articles for article (PubMed ID: 35952929)
21. Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institution.
Turaka K; Bryan JS; De Souza S; Gordon AJ; Kwong HM; Ziemianski MC; Reddy R; Sell CH
Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):412-7. PubMed ID: 22995952
[TBL] [Abstract][Full Text] [Related]
22. Rapid detection of the MYD88 L265P mutation for pre- and intra-operative diagnosis of primary central nervous system lymphoma.
Yamaguchi J; Ohka F; Kitano Y; Maeda S; Motomura K; Aoki K; Takeuchi K; Nagata Y; Hattori H; Tsujiuchi T; Motomura A; Nishikawa T; Kibe Y; Shinjo K; Kondo Y; Saito R
Cancer Sci; 2023 Jun; 114(6):2544-2551. PubMed ID: 36859777
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma.
Chen X; Hu Y; Su W; Yang S; Wang X; Zhang P; Hong X; Liang C; Qian Z; Li Z; Tao Y; Huang H; Liang D
Cancer Commun (Lond); 2022 Nov; 42(11):1217-1221. PubMed ID: 35920016
[No Abstract] [Full Text] [Related]
24. Single-cell MYD88 sequencing of isolated B cells from vitreous biopsies aids vitreoretinal lymphoma diagnosis.
Tan WJ; Wang MM; Ricciardi-Castagnoli P; Tang T; Chee SP; Lim TS; Chan ASY
Blood; 2019 Aug; 134(8):709-712. PubMed ID: 31292111
[No Abstract] [Full Text] [Related]
25. High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates.
Bonzheim I; Giese S; Deuter C; Süsskind D; Zierhut M; Waizel M; Szurman P; Federmann B; Schmidt J; Quintanilla-Martinez L; Coupland SE; Bartz-Schmidt KU; Fend F
Blood; 2015 Jul; 126(1):76-9. PubMed ID: 25900979
[TBL] [Abstract][Full Text] [Related]
26. Comparative Molecular Analysis of Primary Central Nervous System Lymphomas and Matched Vitreoretinal Lymphomas by Vitreous Liquid Biopsy.
Balikov DA; Hu K; Liu CJ; Betz BL; Chinnaiyan AM; Devisetty LV; Venneti S; Tomlins SA; Cani AK; Rao RC
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576156
[TBL] [Abstract][Full Text] [Related]
27. Presentation, Diagnostic Testing and Initial Treatment of Vitreoretinal Lymphoma.
International Vitreoretinal B-Cell Lymphoma Registry Investigator Group
Ophthalmol Retina; 2024 Jan; 8(1):72-80. PubMed ID: 37648063
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal Analysis of Ocular Manifestation and Interleukin During Intravitreal Treatment of Vitreoretinal Lymphoma With Methotrexate.
Gu J; Jiang T; Liu S; Chen X; Wang Z; Zhang P; Wang L; Jiang R; Huang X; Xu G; Chang Q
Am J Ophthalmol; 2023 Jul; 251():189-196. PubMed ID: 36963600
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic methods for primary vitreoretinal lymphoma: A systematic review.
Huang RS; Mihalache A; Popovic MM; Cruz-Pimentel M; Pandya BU; Muni RH; Kertes PJ
Surv Ophthalmol; 2024; 69(3):456-464. PubMed ID: 38163550
[TBL] [Abstract][Full Text] [Related]
30. The diagnostic value of IL-10 and IL-6 level in vitreous fluid and aqueous humor for vitreoretinal lymphoma.
Chen K; Li X; Wang D; Ma Y; Chen B; Wang Q; Ma J; Guan M
Clin Chim Acta; 2021 Apr; 515():21-26. PubMed ID: 33387464
[TBL] [Abstract][Full Text] [Related]
31. Curious case of bilateral non-resolving vitritis - Unmasking the masquerade on ultra-widefield imaging.
Delhiwala K
Indian J Ophthalmol; 2022 Apr; 70(4):1438-1439. PubMed ID: 35326082
[TBL] [Abstract][Full Text] [Related]
32. A pilot study of the use of dynamic analysis of cell-free DNA from aqueous humor and vitreous fluid for the diagnosis and treatment monitoring of vitreoretinal lymphomas.
Wang X; Su W; Gao Y; Feng Y; Wang X; Chen X; Hu Y; Ma Y; Ou Q; Liang D; Huang H
Haematologica; 2022 Sep; 107(9):2154-2162. PubMed ID: 35142151
[TBL] [Abstract][Full Text] [Related]
33. MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab era.
Nishimura N; Takeuchi K; Asaka R; Tuyama N; Inoue N; Kusano Y; Mishima Y; Yokoyama M; Terui Y
Leuk Res; 2020 Oct; 97():106426. PubMed ID: 32781214
[TBL] [Abstract][Full Text] [Related]
34. Transient Bacillary Layer Detachment During the Disease Course of Primary Vitreoretinal Lymphoma.
Casalino G; Malerba A; Fabris S; Bolli N; Croci GA; Pellegrini M; Rossi FG; Mapelli C; Viola F
Ocul Immunol Inflamm; 2024 Jun; ():1-6. PubMed ID: 38838286
[TBL] [Abstract][Full Text] [Related]
35. A Case of Spontaneous Regression and Recurrence of Primary Vitreoretinal Lymphoma.
Kim Y; Shin S; Lee ST; Lee CS
Ocul Immunol Inflamm; 2022; 30(7-8):1980-1983. PubMed ID: 34255584
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma.
Rajagopal R; Harbour JW
Retina; 2011 Mar; 31(3):435-40. PubMed ID: 21336066
[TBL] [Abstract][Full Text] [Related]
37. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
38. A proposed protocol of intravitreal injection of methotrexate for treatment of primary vitreoretinal lymphoma.
Zhou N; Xu X; Liu Y; Wang Y; Wei W
Eye (Lond); 2022 Jul; 36(7):1448-1455. PubMed ID: 34211136
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of disease-specific MYD88 mutations in circulating DNA in primary central nervous system lymphoma.
Hattori K; Sakata-Yanagimoto M; Suehara Y; Yokoyama Y; Kato T; Kurita N; Nishikii H; Obara N; Takano S; Ishikawa E; Matsumura A; Hasegawa Y; Chiba S
Cancer Sci; 2018 Jan; 109(1):225-230. PubMed ID: 29151258
[TBL] [Abstract][Full Text] [Related]
40. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab.
Rishi P; Maitra P; Das K; Rishi E; Manchegowda PT
Int Ophthalmol; 2021 Aug; 41(8):2711-2722. PubMed ID: 33834345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
